242 related articles for article (PubMed ID: 7935472)
21. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
Speck NA; Renjifo B; Golemis E; Fredrickson TN; Hartley JW; Hopkins N
Genes Dev; 1990 Feb; 4(2):233-42. PubMed ID: 2338244
[TBL] [Abstract][Full Text] [Related]
22. Identification of a killer cell-specific regulatory element of the mouse perforin gene: an Ets-binding site-homologous motif that interacts with Ets-related proteins.
Koizumi H; Horta MF; Youn BS; Fu KC; Kwon BS; Young JD; Liu CC
Mol Cell Biol; 1993 Nov; 13(11):6690-701. PubMed ID: 8413265
[TBL] [Abstract][Full Text] [Related]
23. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro.
Sheridan PL; Sheline CT; Cannon K; Voz ML; Pazin MJ; Kadonaga JT; Jones KA
Genes Dev; 1995 Sep; 9(17):2090-104. PubMed ID: 7657162
[TBL] [Abstract][Full Text] [Related]
24. Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells.
Martin ME; Yang XY; Folk WR
Mol Cell Biol; 1992 May; 12(5):2213-21. PubMed ID: 1569949
[TBL] [Abstract][Full Text] [Related]
25. Both LyF-1 and an Ets protein interact with a critical promoter element in the murine terminal transferase gene.
Ernst P; Hahm K; Smale ST
Mol Cell Biol; 1993 May; 13(5):2982-92. PubMed ID: 8474456
[TBL] [Abstract][Full Text] [Related]
26. A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers.
Thiesen HJ; Bösze Z; Henry L; Charnay P
J Virol; 1988 Feb; 62(2):614-8. PubMed ID: 2826819
[TBL] [Abstract][Full Text] [Related]
27. Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer.
Fu GK; Markovitz DM
J Biol Chem; 1996 Aug; 271(32):19599-605. PubMed ID: 8702655
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells.
Satake M; Inuzuka M; Shigesada K; Oikawa T; Ito Y
Jpn J Cancer Res; 1992 Jul; 83(7):714-22. PubMed ID: 1325429
[TBL] [Abstract][Full Text] [Related]
29. Nuclear factor-1 (NF-1) binds to multiple sites within the transcriptional enhancer of Moloney murine leukemia virus.
Reisman D
FEBS Lett; 1990 Dec; 277(1-2):209-11. PubMed ID: 2269357
[TBL] [Abstract][Full Text] [Related]
30. A composite Ets/Pit-1 binding site in the prolactin gene can mediate transcriptional responses to multiple signal transduction pathways.
Howard PW; Maurer RA
J Biol Chem; 1995 Sep; 270(36):20930-6. PubMed ID: 7673116
[TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.
Wang S; Wang Q; Crute BE; Melnikova IN; Keller SR; Speck NA
Mol Cell Biol; 1993 Jun; 13(6):3324-39. PubMed ID: 8497254
[TBL] [Abstract][Full Text] [Related]
32. Sequence specific binding of Ets-1 to the mouse cytokeratin EndoA gene enhancer.
Hamazato F; Fujimura Y; Tamai Y; Takemoto Y; Matsushiro A; Nozaki M
Biochem Biophys Res Commun; 1993 Apr; 192(2):430-8. PubMed ID: 7683460
[TBL] [Abstract][Full Text] [Related]
33. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
34. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
35. Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro.
Mayall TP; Sheridan PL; Montminy MR; Jones KA
Genes Dev; 1997 Apr; 11(7):887-99. PubMed ID: 9106660
[TBL] [Abstract][Full Text] [Related]
36. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
[TBL] [Abstract][Full Text] [Related]
37. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
38. A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer.
Rao E; Dang W; Tian G; Sen R
J Biol Chem; 1997 Mar; 272(10):6722-32. PubMed ID: 9045705
[TBL] [Abstract][Full Text] [Related]
39. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer.
Henkel G; Brown MA
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7737-41. PubMed ID: 8052653
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional activation through ETS domain binding sites in the cytochrome c oxidase subunit IV gene.
Virbasius JV; Scarpulla RC
Mol Cell Biol; 1991 Nov; 11(11):5631-8. PubMed ID: 1656236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
